Legal Representation
Attorney
Chelsea E. Carbone
USPTO Deadlines
Next Deadline
106 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
February 22, 2026
Extension Available
Until August 22, 2024
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 13, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 11, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 10, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 14, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 12, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 12, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 14, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 14, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 14, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 14, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 23, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 23, 2024 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Mar 22, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Mar 22, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 29, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 6, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Feb 6, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Feb 5, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 5, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 22, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 27, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 27, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 7, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 25, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 25, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 25, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 25, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 25, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 24, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 22, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 22, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 23, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 23, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 23, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 8, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 27, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 25, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical test kits for diagnosing, monitoring, and treating infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders for laboratory or research use; assays for research purposes; assays for testing blood and other bodily fluids for research purposes; assays and reagents for use in infectious disease, oncology, autoimmunity, cardiovascular, and neurological disorders research
Class 005
Medical diagnostic reagents and assays for testing and analyzing blood and other bodily fluids; diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood and other bodily fluids for use in disease and disorder detection, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; pharmaceutical preparations for use in treating infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; drug testing kits comprised of medical diagnostic reagents and assays for testing blood and other bodily fluids; diagnostic reagents for medicinal use
Class 009
Downloadable computer software using artificial intelligence (AI) and machine learning for analysis of immune data for the purposes of medical research, diagnosis, and treatment; downloadable computer software using artificial intelligence (AI) and machine learning for analysis of immune data for the purposes of identifying, prescribing, and monitoring medications; downloadable computer software using artificial intelligence (AI) and machine learning for diagnosing, monitoring, and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; software as a Medical Device (SaMD), downloadable, for analyzing the immune system for the purposes of medical diagnosis and treatment; software as a Medical Device (SaMD), downloadable, for analyzing the immune system for the purposes of identifying, prescribing and monitoring medications; software as a Medical Device (SaMD), downloadable, for diagnosing, monitoring and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; computer hardware; computer hardware with imbedded software for diagnosing, monitoring, and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids
Class 010
Medical device for detecting diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; medical device, namely, medical device for disease and disorder diagnosis, monitoring of biological material and cell populations, and medical treatment device in the nature of medical devices for the interrogation of biological samples; medical devices for detection and treatment of infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; apparatus for blood analysis; apparatus for taking blood samples; blood collection kit comprised of medical tubes and vials, tube and vial holders, and transportation device and blood testing apparatus; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of infectious disease, oncology, autoimmunity, cardiovascular, and neurological disorders; laboratory apparatus, namely, diagnostic apparatus for the interrogation of biological samples featuring artificial intelligence (AI) and machine learning recorded software for medical diagnosis, monitoring, and treatment of diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; laboratory apparatus, namely, diagnostic apparatus for the interrogation of biological samples featuring artificial intelligence (AI) and machine learning recorded software for monitoring the immune system for the purposes of identifying, prescribing, and monitoring medications; laboratory apparatus and instruments in the nature of medical devices and diagnostic apparatus for the interrogation of biological samples for diagnosing diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders
Classification
International Classes
001
005
009
010